1. Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells. Issue 5 (31st March 2020) Authors: Ueda, Tatsuki; Kumagai, Ayako; Iriguchi, Shoichi; Yasui, Yutaka; Miyasaka, Tadayo; Nakagoshi, Kengo; Nakane, Kazuki; Saito, Keigo; Takahashi, Mari; Sasaki, Aki; Yoshida, Shinsuke; Takasu, Naoko; Seno, Hiroshi; Uemura, Yasushi; Tamada, Koji; Nakatsura, Tetsuya; Kaneko, Shin Journal: Cancer science Issue: Volume 111:Issue 5(2020) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reprogramming away from the exhausted T cell state. Issue 1 (February 2016) Authors: Karagiannis, Peter; Iriguchi, Shoichi; Kaneko, Shin Journal: Seminars in immunology Issue: Volume 28:Issue 1(2016) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Toward the development of true "off‐the‐shelf" synthetic T‐cell immunotherapy. Issue 1 (1st January 2019) Authors: Iriguchi, Shoichi; Kaneko, Shin Journal: Cancer science Issue: Volume 110:Issue 1(2019) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗